Vynleads

Vynleads on AI Visit Preparation and Why Structure Matters

Rock Hill, S.C. – November 2, 2026 – Vynleads (OTCQB: VYND) today shared an AI-scope perspective on a preprint posted October 30, 2026 to arXiv, “A prospective randomized study of patient-centered AI for clinical visit preparation.” The study, run in the Google Health app, compared a structured AI agent that helps people prepare for a doctor’s visit with a minimally prompted chatbot built on the same AI model.

What the Study Reported

According to the preprint, 5,960 U.S. adults in the Google Health app consented and were randomized, and 802 adults who held 866 health-related conversations were included in the analysis. The structured agent was designed to gather clinical context, set expectations for the visit, give relevant health information, build a prioritized list of questions for the clinician, and produce a summary. According to i10X News, which covered the preprint, the study arms differed only in the instructions given to the AI, and Google designed, ran and funded the study.

In surveys taken right after the session (460 responses), 73.8% of people who used the structured agent said they felt prepared for their visit, compared with 57.0% for the control chatbot. Clinicians who reviewed 272 completed sessions, without knowing which arm each came from, rated the structured agent’s sessions as comprehensive more often (67.2% vs. 50.6%). The authors report high medical safety and appropriateness across all study arms, and they found that the patient and clinician measures were not significantly correlated.

The preprint also sets out limits. It has not been peer-reviewed. The results describe how prepared people felt and how clinicians rated the conversations, not whether visits or health outcomes changed, and the authors call for future studies of clinical outcomes. Of the included conversations, 42.3% ended before the full preparation flow was complete. The 14-day follow-up survey received 95 responses. Participants were English-speaking adults using the Google Health app on Android phones who opted into a research study, and the authors note they were likely more technologically engaged and health literate than the general patient population.

Vynleads was not involved in the study and takes no position on its clinical validity, its methods, or the products it tested. The company’s interest is in the design question the study raises: how tightly an AI tool’s job is defined, and what happens when a person stops partway through.

A Narrow Job and a Clear Finish Line

“I read this study as a clear sign that in health AI, the job you give the model matters as much as the model itself. In my view, the risk with a general chatbot was never that it knows too little. It’s that it will talk about anything for as long as you keep typing, and nothing tells you when you’re done. What I’ve learned building this company is that the hardest design work in health AI is subtraction: one narrow job, a clear finish line, and the person’s own care team on the other side of it. We built Done With Diabetes so the AI sits beside a person’s care and never stands in for it, and that boundary is a design decision, not a disclaimer. The bar I hold us to is not whether people feel ready, but whether they take the next step, and I expect this category to be judged on that difference.”

— Alex Mannine, Co-Founder and CEO, Vynleads

Related reading from the Vynleads library: a checklist for preparing for a diabetes appointment, how AI wellness coaching differs from medical advice, what a diabetes chatbot should never do, and whether an AI diabetes coach is safe.

Feeling Ready Is Not the Same as Doing

For readers following the company, Vynleads reads the preprint as a signal about where health AI is heading. The authors note that millions of adults now turn to general-purpose AI chatbots to prepare for visits; the study tested what changes when the same AI is given a defined job with a beginning, a middle and an end. In the company’s view, that points the category toward scoped, structured tools that sit beside a person’s care, rather than open-ended chat that tries to answer everything.

The company also reads the study’s limits as part of the signal. Feeling prepared is a measure of readiness, not proof that a person asked their questions, followed a plan, or received better care. In Vynleads’ reading, the conversations that ended early, and the people a sample like this is least likely to reach, including many older adults and people less at ease with technology, belong in the safety conversation rather than a footnote. The company believes employers, health plans and product teams evaluating AI support are likely to ask where the tool’s job starts and stops, what happens when someone leaves partway through, and how the program shows that a next step was actually taken. Vynleads discussed related questions in its comments on where everyday AI support ends and the care team begins and what the hours between appointments are for.

Vynleads’ positioning is built around those questions: a non-clinical scope set by design, a structure-first 8-week program with daily lessons and saved progress rather than open-ended chat, lifestyle inputs rather than clinical records, safety checks and escalation paths behind the AI, and a direct-to-consumer wellness model that sits beside a person’s care rather than in place of it. This release announces no partner, payer, or employer relationship.

In the company’s view, the bar for AI support in health is evidence that people complete the next step, not only that they feel ready for it. Vynleads believes that standard will matter more as AI tools move closer to everyday care, and it is the standard the company is building toward, from its flagship Done With Diabetes™ program to its planned “Done With (DWX)” portfolio.

Where Done With Diabetes™ Fits

The Done With Diabetes™ program pairs a structured 8-week Success Blueprint with Coach Smith, the AI wellness assistant: educational lifestyle support with safety checks, never medical advice, built on the company’s AI coaching technology. Coach Smith can help a person write down questions to bring to their next visit. It does not diagnose, treat, or comment on medication, and it points people toward professional care when a conversation moves beyond daily habits. Learn more about Vynleads.

Resources:

Vynleads is not affiliated with Google, Alphabet, arXiv, or i10X News, or with any author of the study, and Vynleads was not part of this study. This commentary is a non-clinical business and product-design perspective; it takes no position on the study’s clinical validity, methods, or conclusions, or on any company’s products, and it is not medical advice. It makes no claim about blood sugar, weight, engagement, retention, or other outcomes for any Vynleads program. Decisions about diagnosis, medication, and treatment belong with each person and their qualified care team. Done With Diabetes™ provides educational lifestyle support for general wellness; it does not provide medical advice, diagnosis, or treatment.